Galmed Pharmaceuticals (GLMD) Asset Utilization Ratio (2017 - 2019)
Galmed Pharmaceuticals (GLMD) recorded quarterly Asset Utilization Ratio of 0.02 in Q2 2019, down 7.86% quarter-over-quarter from 0.02 in Q4 2018, and up 4.84% on a YoY basis from 0.02 in Q2 2018.
Galmed Pharmaceuticals (GLMD) Asset Utilization Ratio (2017 - 2019) Analysis & Trends
Galmed Pharmaceuticals' Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.02 for Q2 2019.
- In Q2 2019, Asset Utilization Ratio rose 4.84% year-over-year to 0.02; the TTM figure through Jun 2019 stood at 0.02 (up 4.84% YoY), while the FY2018 annual figure was 0.04, down 38.5% from the prior year.
- Asset Utilization Ratio was 0.02 for Q2 2019 at Galmed Pharmaceuticals, down from 0.02 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.11 in Q3 2017 to a low of 0.02 in Q2 2018.
- Historically, Asset Utilization Ratio has averaged 0.05 across 3 years, with a median of 0.05 in 2017.
- Biggest YoY gain for Asset Utilization Ratio was 19.53% in 2018; the steepest drop was 77.97% in 2018.
- A 3-year view of Asset Utilization Ratio shows it stood at 0.07 in 2017, then tumbled by 69.99% to 0.02 in 2018, then slipped by 7.86% to 0.02 in 2019.
- The last three Asset Utilization Ratio figures came in at 0.02 (Q2 2019), 0.02 (Q4 2018), and 0.02 (Q3 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Galmed Pharmaceuticals | 2.48 Mn | -1.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 0.02 |
| Dec 31, 2018 | 0.02 |
| Sep 30, 2018 | 0.02 |
| Jun 30, 2018 | 0.02 |
| Mar 31, 2018 | 0.06 |
| Dec 31, 2017 | 0.07 |
| Sep 30, 2017 | 0.11 |
| Jun 30, 2017 | 0.09 |
| Mar 31, 2017 | 0.05 |